Register information Protection certificate

DE file number : 12 2016 000 086.2 (Status: pending/in force, Query started: April 29, 2025)

Please note: This English version is a non-binding translation of the German register excerpt. Only the German version of the register excerpt is legally binding.

Master data
INIDCriterionFieldContent
Type of IP rightSARTProtection certificate
StatusSTPending/in force
21DE file number DAKZ12 2016 000 086.2
UseVZMedicinal products
95Product nameTIEZalbutrepenonacog alfa
54Title of basic patentTIGZAlbuminfusionsproteine
51IPC main classICM
(ICMV)		 C12N 15/62 (2006.01)
51IPC secondary class(es)ICS
(ICSV)		 C07K 14/765 (2006.01), C07K 14/52 (2006.01)
94Start of term of protectionLBApr 13, 2021
94End of term of protectionLEApr 12, 2026
22DE application dateDATNov 3, 2016
Date of publication of application for a certificateOTDec 22, 2016
Date of publication of grant of certificatePETMay 6, 2021
71/73Applicant/ownerINHNovozymes Biopharma DK A/S, Krogshoejveg 36, Bagsvaerd, DK
74RepresentativeVTRBrinkmann & Partner Patentanwälte Partnerschaft mbB, 40547 Düsseldorf, DE
Address for service Brinkmann & Partner Patentanwälte Partnerschaft mbB, 40547 Düsseldorf, DE
Patent division in charge 44
68DE file number of basic patentGAKZ601 49 151.3
68EP file number of basic patentGEAKZ10 07 5011.6
43Date of first publicationEVTDec 22, 2016
92
92
92
Domestic authorisationGIS
GIN
GIT
Europäische Kommission
EU/1/16/1095
2016-05-11
93
93
93
93
EU authorisationGES
GEC
GEN
GET
Europäische Kommission
EU
EU/1/16/1095
2016-05-11
Date of the first transfer into DPMAregisterEREGTDec 22, 2016
Date of the (most recent) update in DPMAregisterREGTApr 2, 2025
(Show all update days)(Hide all update days)
  • Apr 2, 2025
    • Due date: deleted
  • Aug 14, 2024
    • St.36: changed (technical change)
  • Apr 11, 2024; Apr 5, 2023; Apr 9, 2022; Jun 16, 2021; Apr 18, 2021; Mar 28, 2021; Mar 27, 2021; Mar 18, 2021; Mar 16, 2021; Mar 12, 2021; Jul 16, 2019; Aug 7, 2018; Aug 15, 2017
    • Historical data not available for this/these date(s)
  • Dec 22, 2016
    • Date of the first transfer into DPMAregister
Procedural data
No.Kind of procedureLegal statusDate of legal/procedural statusPublication dateAlle Details anzeigen
1 Supplementary protection certificate procedure Application for supplementary protection certificate effectively filed Nov 16, 2016 Dec 22, 2016 Details anzeigen
2 New applicant/owner details New applicant/owner details Aug 14, 2017  Details anzeigen
3 New applicant/owner details New applicant/owner details Aug 6, 2018  Details anzeigen
4 New representative details New representative details Mar 11, 2021  Details anzeigen
5 Supplementary protection certificate procedure Decision to grant supplementary protection certificate by Patent Division Mar 17, 2021  Details anzeigen
6 Supplementary protection certificate procedure Supplementary protection certificate granted Mar 24, 2021 May 6, 2021 Details anzeigen
View procedures Supplementary protection certificate procedure (No.: 1)
INIDCriterionFieldContent Close details
Type of procedureVARTProtection certificate procedure
Legal/procedural statusVSTApplication for supplementary protection certificate effectively filed
Date of legal/procedural statusVSTTNov 16, 2016
Issue numberHN51
YearPJ2016
Publication dateVTDec 22, 2016
Type of publicationPARTBibliographic data
PartHTPart 7
68DE file number of basic patentGAKZ601 49 151.3
68EP file number of basic patentGEAKZ10 07 5011.6
View procedures New applicant/owner details (No.: 2)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTAug 14, 2017
71/73Applicant/ownerINHAlbumedix A/S, 2800 Kgs Lyngby, DK
71/73Previous applicant/ownerINHFNovozymes Biopharma DK A/S, Bagsvaerd, DK
View procedures New applicant/owner details (No.: 3)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTAug 6, 2018
71/73Applicant/ownerINHNovozymes Biopharma DK A/S, Bagsvaerd, DK
71/73Previous applicant/ownerINHFAlbumedix A/S, 2800 Kgs Lyngby, DK
View procedures New representative details (No.: 4)
INIDCriterionFieldContent Close details
Type of procedureVARTNew representative details
Legal/procedural statusVSTNew representative details
Date of legal/procedural statusVSTTMar 11, 2021
74RepresentativeVTRBrinkmann & Partner Patentanwälte Partnerschaft mbB, 40547 Düsseldorf, DE
74Previous representativeVTRFStenger Watzke Ring intellectual property, 40547 Düsseldorf, DE
Date of update of the procedureREGTJun 16, 2021
View procedures Supplementary protection certificate procedure (No.: 5)
INIDCriterionFieldContent Close details
Type of procedureVARTProtection certificate procedure
Legal/procedural statusVSTDecision to grant supplementary protection certificate by Patent Division
Date of legal/procedural statusVSTTMar 17, 2021
Date of update of the procedureREGTMar 18, 2021
View procedures Supplementary protection certificate procedure (No.: 6)
INIDCriterionFieldContent Close details
Type of procedureVARTProtection certificate procedure
Legal/procedural statusVSTSupplementary protection certificate granted
Date of legal/procedural statusVSTTMar 24, 2021
Issue numberHN18
YearPJ2021
Publication dateVTMay 6, 2021
Type of publicationPARTBibliographic data
PartHTPart 7
Date of update of the procedureREGTApr 18, 2021